Professor of Surgery
Division of Pediatric Surgery
Baylor College of Medicine
William J. Pokorny, M.D. Professorship in Pediatric Surgery
Baylor College of Medicine
Professor of Surgery
Division of Pediatric Surgery
Texas Children's Hospital
Chief, Global Surgery
Baylor College of Medicine


Advanced Training from Baylor College Of Medicine Affiliate Hospitals
Advanced Training from University Of Washington Hospital
Advanced Training from National Institutes Of Health
Advanced Training from University Of Washington Hospital
M.D. from Harvard Medical School
A.M. from Harvard University
A.B. from Princeton University


Board Certified - Pediatric Surgery
American Board of Surgery
Board Certified - General Surgery
American Board of Surgery
Board Certified - Surgical Critical Care
American Board of Surgery

Honors & Awards

Master Clinician Award for Excellence in Patient Care
Top Doctor
Top Doctors for Kids
America’s Top Doctors for Cancer
Best Doctors in America
Distinguished Surgeon Award
Who’s Who in America

Professional Interests

  • Pediatric surgical oncology
  • Adrenal tumors

Professional Statement

Dr. Jed G. Nuchtern is committed to providing pediatric surgical care with special attention to the surgical needs of children with cancer and the needs of their families. This philosophy combines dedication to exceptional education and training, advanced research, and the development of newer and better treatments and procedures.

Dr. Nuchtern takes an active role in the education and mentoring of the fellows, and residents and medical students on rotation to the Pediatric Surgery Service at Texas Children’s Hospital.

Dr. Nuchtern leads a collaborative research program that includes translational and clinical research on developing new treatments for pediatric solid tumors, particularly neuroblastoma. The primary focus in his laboratory is identifying new targets for neuroblastoma therapy. Bioinformatic studies have identified several proteins whose expression is increased in high-risk neuroblastoma tumors. The laboratory has validated these findings and demonstrated that blocking the expression of these target proteins decreases tumor growth and progression. Current research seeks to identify the pathways through which these molecules affect tumor progression.

In addition to these translational studies, Dr. Nuchtern is involved in clinical research on neuroblastoma in infants. Through the Children’s Oncology Group, he designed and implemented a prospective international study investigating the safety and efficacy of expectant observation as the primary treatment modality for infants with low risk adrenal tumors.

Selected Publications


American Academy of Pediatrics
American College of Surgeons
American Society of Clinical Oncology
American Pediatric Surgical Association
Association for Academic Surgery
International Society for Pediatric Surgical Oncology
Society of Critical Care Medicine
Southwestern Surgical Congress
Society of University Surgeons